What does MSB stand for?

Excludes mandatory escrowed shares and foreign shares. Mesoblast Limited (MSB) is an Australian company engaged in the development of regenerative medicine products. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp cells and Adipose cells.

What are the terms of use of ASX market announcements?

The access to and use of information made available on the ASX website, including Market Announcements, is subject to the terms of use. Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. Index data is provided © S&P Dow Jones Indices LLC 2020.

How long do MSB directors have to report to the ASX?

MSB directors must report any change in shareholding to the ASX within 5 business days. See Director Transactions for all ASX companies. The current holdings of MSB directors. The Top 20 Shareholders of MSB hold 0% of shares on issue. As reported in the most recent Annual Report.

What is MSB's principal activity?

MSB's Principal Activity is the research and development of Mesenchymal Lineage Adult Stem Cell (MLCs) technology platform characterized by distinct properties which enable allogeneic or off the shelf use. Excludes mandatory escrowed shares and foreign shares.